EPIGENETIC MECHANISMS IN SJÖGREN'S SYNDROME - Université de Bretagne Occidentale Accéder directement au contenu
Article Dans Une Revue European Medical Journal Année : 2016

EPIGENETIC MECHANISMS IN SJÖGREN'S SYNDROME

Résumé

Primary Sjögren’s syndrome (pSS) is a systemic autoimmune epithelitis and recent advances in our comprehension of its pathophysiology strongly suggest a multi-step process that involves environmental factors (e.g. chronic viral infection, drugs), followed by deregulation of the epigenetic machinery (e.g. DNA demethylation, histone modifications, microRNAs), which in turn specifically affects lymphocytes and epithelial cells leading to an aberrant inflammation. This process is amplified in the case of genetic mutations. As a consequence, autoreactive lymphocytes and autoantigens are produced leading to the development of autoantibodies. Moreover, it was observed that epigenetic modifications in pSS could be reversed, thus providing arguments to suggest that therapeutic strategies targeting the epigenetic deregulation and in particular the PKC-delta/Erk/DNMT1 pathway would be effective in pSS.
Fichier principal
Vignette du fichier
CLDAC.pdf (530.31 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01449169 , version 1 (05-12-2017)

Identifiants

  • HAL Id : hal-01449169 , version 1

Citer

Christelle Le Dantec, Amandine Charras, Anne Bordron, Wesley H Brooks, Yves Renaudineau. EPIGENETIC MECHANISMS IN SJÖGREN'S SYNDROME. European Medical Journal, 2016. ⟨hal-01449169⟩

Collections

UNIV-BREST IMMUNO
124 Consultations
78 Téléchargements

Partager

Gmail Facebook X LinkedIn More